Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6474 publications

Plasma N-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD.

Plasma N-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 16, 2025

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 06, 2025

Systemic Lupus Erythematosus in a patient with Aquaporin 4-Positive Neuromyelitis Optica Spectrum Disorder.

Systemic Lupus Erythematosus in a patient with Aquaporin 4-Positive Neuromyelitis Optica Spectrum Disorder.

Journal: Archive of clinical cases
Published: October 02, 2025

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): What controversies remain?

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): What controversies remain?

Journal: Medicina
Published: October 02, 2025

Neuromyelitis optica spectrum disorder: new international recommendations and emerging therapeutic options; current status of domestic practice in diagnostics and therapeutic strategies

Neuromyelitis optica spectrum disorder: new international recommendations and emerging therapeutic options; current status of domestic practice in diagnostics and therapeutic strategies

Journal: Ideggyogyaszati szemle
Published: October 01, 2025

Corrigendum to "Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches" [Experim. Eye Res. 256 110395].

Corrigendum to "Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches" [Experim. Eye Res. 256 110395].

Journal: Experimental eye research
Published: September 24, 2025

Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape.

Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape.

Journal: Expert opinion on emerging drugs
Published: September 23, 2025

CRISPR and Myelin regeneration: a systematic review of applications in demyelinating CNS Disorders, with a focus on MS.

CRISPR and Myelin regeneration: a systematic review of applications in demyelinating CNS Disorders, with a focus on MS.

Journal: Regenerative medicine
Published: September 20, 2025

Advances in the therapeutic landscape for neuromyelitis optica spectrum disorder.

Advances in the therapeutic landscape for neuromyelitis optica spectrum disorder.

Journal: Expert review of neurotherapeutics
Published: September 18, 2025

The cascade sign in aquaporin-4-IgG positive (AQP4-IgG+) NMOSD.

The cascade sign in aquaporin-4-IgG positive (AQP4-IgG+) NMOSD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 16, 2025

Unraveling the spectrum of the antibody-mediated demyelinating diseases: Emerging insights.

Unraveling the spectrum of the antibody-mediated demyelinating diseases: Emerging insights.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 13, 2025

Machine learning algorithms for predicting neuromyelitis optica relapses.

Machine learning algorithms for predicting neuromyelitis optica relapses.

Journal: Multiple sclerosis and related disorders
Published: September 12, 2025
Showing 1-12 of 6,474

Last Updated: 10/31/2025